Baxter A et al. |
Squalestatin 1, a potent inhibitor of squalene synthase, which lowers serum cholesterol in vivo. |
1992 |
J. Biol. Chem. |
pmid:1601846
|
Correll CC and Edwards PA |
Mevalonic acid-dependent degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase in vivo and in vitro. |
1994 |
J. Biol. Chem. |
pmid:8276863
|
Vukelic S et al. |
Farnesyl pyrophosphate inhibits epithelialization and wound healing through the glucocorticoid receptor. |
2010 |
J. Biol. Chem. |
pmid:19903814
|
Brusselmans K et al. |
Squalene synthase, a determinant of Raft-associated cholesterol and modulator of cancer cell proliferation. |
2007 |
J. Biol. Chem. |
pmid:17483544
|
Kahlon AK et al. |
Molecular docking studies to map the binding site of squalene synthase inhibitors on dehydrosqualene synthase of Staphylococcus aureus. |
2010 |
J. Biomol. Struct. Dyn. |
pmid:20645653
|
Pastar I et al. |
Skin Metabolite, Farnesyl Pyrophosphate, Regulates Epidermal Response to Inflammation, Oxidative Stress, and Migration. |
2016 |
J. Cell. Physiol. |
pmid:26916741
|
Linetti A et al. |
Cholesterol reduction impairs exocytosis of synaptic vesicles. |
2010 |
J. Cell. Sci. |
pmid:20103534
|
Zúñiga-Hertz JP et al. |
Distinct pathways of cholesterol biosynthesis impact on insulin secretion. |
2015 |
J. Endocrinol. |
pmid:25453115
|
Stein W et al. |
Prevention of transplant coronary artery disease by prenylation inhibitors. |
2011 |
J. Heart Lung Transplant. |
pmid:21458297
|
Molina S et al. |
The low-density lipoprotein receptor plays a role in the infection of primary human hepatocytes by hepatitis C virus. |
2007 |
J. Hepatol. |
pmid:17156886
|
Doerner KC et al. |
Regulation of cholesterol 7 alpha-hydroxylase expression by sterols in primary rat hepatocyte cultures. |
1995 |
J. Lipid Res. |
pmid:7665995
|
Petras SF et al. |
HMG-CoA reductase regulation: use of structurally diverse first half-reaction squalene synthetase inhibitors to characterize the site of mevalonate-derived nonsterol regulator production in cultured IM-9 cells. |
1999 |
J. Lipid Res. |
pmid:9869647
|
Quade-Lyssy P et al. |
Statins stimulate the production of a soluble form of the receptor for advanced glycation end products. |
2013 |
J. Lipid Res. |
pmid:23966666
|
Procopiou PA et al. |
The squalestatins: novel inhibitors of squalene synthase. Enzyme inhibitory activities and in vivo evaluation of C1-modified analogues. |
1994 |
J. Med. Chem. |
pmid:7932554
|
Biftu T et al. |
Selective protection and relative importance of the carboxylic acid groups of zaragozic acid A for squalene synthase inhibition. |
1994 |
J. Med. Chem. |
pmid:8308869
|
Bamford MJ et al. |
The squalestatins: synthesis and biological activity of some C3-modified analogues; replacement of a carboxylic acid or methyl ester with an isoelectronic heterocyclic functionality. |
1995 |
J. Med. Chem. |
pmid:7658437
|
Procopiou PA et al. |
The squalestatins: inhibitors of squalene synthase. Enzyme inhibitory activities and in vivo evaluation of C3-modified analogues. |
1996 |
J. Med. Chem. |
pmid:8691471
|
Ponpipom MM et al. |
Structure-activity relationships of C1 and C6 side chains of zaragozic acid A derivatives. |
1994 |
J. Med. Chem. |
pmid:7966163
|
Pedretti A et al. |
Modeling of binding modes and inhibition mechanism of some natural ligands of farnesyl transferase using molecular docking. |
2002 |
J. Med. Chem. |
pmid:11906287
|
Chan C et al. |
The squalestatins: decarboxy and 4-deoxy analogues as potent squalene synthase inhibitors. |
1996 |
J. Med. Chem. |
pmid:8568810
|